Skip to content

FDA product code · Clinical Chemistry

JITCalibrator, Secondary

Product code JIT covers Calibrator, Secondary, a Class II device regulated under 21 CFR 862.1150. FDA has cleared 245 devices in this code. Median review time across the 245 most recent decisions is 41 days. openFDA lists 55 recall records against this code.

Updated · ingest status · JSON

Class
Class II
Regulation
21 CFR 862.1150
Review panel
Clinical Chemistry
Clearances
245

What is happening in JIT right now?

JIT (Calibrator, Secondary) has one finding. 1 recall opened in the last 12 months and not yet terminated (Z-2894-2026).

Every factor behind the statement above, most consequential first, with the FDA records it came from.
FindingHow much it mattersFDA records
RecallSeriousZ-2894-2026

Sources checked: predicate ancestry, recalls, adverse events, new entrants, review time, crowding. Composed . Every finding carries the record ids it was derived from; nothing here is an estimate.

How many devices has FDA cleared in JIT?

FDA has cleared 245 devices under product code JIT since the 510(k) programme began in 1976.

Source: openFDA device/510k · retrieved

Most recent 510(k) clearances in JIT, newest first.
510(k)DeviceApplicantDecision
K171168VITROS Immunodiagnostic Products Insulin CalibratorsOrtho Clinical Diagnostics
K170938CalSet IGF-1Roche Diagnostics
K170160Abbott ARCHITECT Free T3Abbott Laboratories
K163546Lumipulse G Progesterone-N CalibratorsFujirebio Diagnostics,Inc.
K163534Lumipulse G FSH-N CalibratorsFujirebio Diagnostics,Inc.
K163544Lumipulse G ProlactinFujirebio Diagnostics,Inc.
K163521Lumipulse G LH CalibratorsFujirebio Diagnostics,Inc.
K163078DC-UIBC-CALSekisui Diagnostics P.E.I., Inc.
K163053Lumipulse G E2-III CalibratorsFujirebio Diagnostics,Inc.
K162538ADVIA Centaur Insulin (IRI) Master Curve Material (MCM), ADVIA Centaur (IRI) CalibratorSiemens Healthcare Diagnostics

How long does FDA review take for JIT?

The median FDA review time for JIT is 41 days, measured across the 245 most recent decisions with both a received date and a decision date.

Review time here is decision date minus date received, as published by FDA. It is elapsed calendar time, not FDA review days — the two differ whenever the agency stops the clock for an additional information request.

Source: openFDA device/510k · retrieved

Are there recalls in JIT?

openFDA lists 55 recall records against product code JIT. A recall record covers one firm's corrective action and may span many device lots.

  • Z-2894-2026Open, ClassifiedAniara Diagnostica LLC

    Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

  • Z-1848-2025Open, ClassifiedMckesson Medical-Surgical Inc. Corporate Office

    transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

  • Z-1849-2025Open, ClassifiedMckesson Medical-Surgical Inc. Corporate Office

    transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

  • Z-1850-2025Open, ClassifiedMckesson Medical-Surgical Inc. Corporate Office

    transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

  • Z-1851-2025Open, ClassifiedMckesson Medical-Surgical Inc. Corporate Office

    transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

Showing the 5 most recently initiated of 55. Recall class comes from openFDA's enforcement endpoint, which does not carry every recall — where it is missing, none is shown rather than guessed. Status is FDA's own wording; a terminated recall is a closed one, and the total spans the code's whole history, not just what is open today.

Source: openFDA device/recall · retrieved

How many adverse events are reported for JIT?

MAUDE holds 26 adverse-event reports naming product code JIT.

MAUDE reports are submitted by manufacturers, importers, user facilities and the public. They are unverified, and a report is not proof that the device caused the event.

Source: openFDA device/event · retrieved

Is adverse-event reporting in JIT unusual?

JIT does not yet have twelve months of adverse-event history in our data, so there is no expected range to compare against. That is a gap in what we hold, not a statement about the device.

Monthly adverse-event reports naming JIT, against the expected range computed from this code's own history. Shaded band is the expected range; a bar above it is the month flagged. Retrieved 11 August 2026.
Reports received per month for JIT, with the expected range and whether the month fell outside it.
MonthReportsExpectedVerdict
1Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
2Insufficient historyNo expected range — too little history
2Insufficient historyNo expected range — too little history
6Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
6Insufficient historyNo expected range — too little history
3Insufficient historyNo expected range — too little history
1Insufficient historyNo expected range — too little history
3Insufficient historyNo expected range — too little history

10 months do not have a full, unbroken year of history before them, so no expected range is shown for those. Insufficient history is reported as insufficient rather than as zero: an empty baseline would turn a gap in our data into a spike.

What are the predicate devices in JIT?

FDA publishes no machine-readable predicate field, so no predicate chain is recorded for this code yet.

A predicate chain matters because a device inherits the safety history of what it was compared to. FDA publishes the chain only inside each 510(k) summary PDF, never as data — so where we have edges, they are read from those documents, and where we do not, we say so instead of showing an empty list.

Who files 510(k)s in JIT?

Across the 245 most recent decisions, these applicants filed most often in JIT.

Most frequent applicants in JIT among recent decisions.
ApplicantRecent clearances
Dade Behring, Inc.29
Wako Chemicals USA, Inc.15
E.I. Dupont DE Nemours & Co., Inc.10
Roche Diagnostics Corp.10
Diamond Diagnostics, Inc.9

Applicant names above are exactly as FDA published them, so one company can appear under several spellings.

The same makers, after name resolution

2 companies in JIT file under more than one spelling. Resolving them to one identity — across all six datasets, not just this one — is what makes a joined count possible at all.

Companies in JIT whose FDA filings use more than one spelling of the same name.
CompanyClearancesFDA spellings merged
Roche Diagnostics Corporation182
Siemens Healthcare Diagnostics, Inc.112

Merges are measured against a hand-labelled sample and held above 98% precision; pairs the matcher is unsure of are queued for a person rather than merged. See DeviceSignal.

Source: openFDA device/510k · retrieved

Watch JIT

Get an email the morning anything changes in JIT — a new clearance, a recall, or an adverse-event spike above this code's own baseline.

Start watching JIT

Data on this page comes from FDA's public openFDA API and is US public domain (CC0). DeviceSignal is an independent commercial service and is not affiliated with the U.S. Food and Drug Administration. Information only, not regulatory advice. Verify anything you rely on against open.fda.gov.